Primary spontaneous pneumothorax (PSP) affects young healthy people with a significant
recurrence rate. Recent advances in treatment have been variably implemented in clinical …

Pneumothorax is classified as spontaneous (not caused by trauma or any obvious
precipitating factor), traumatic, or iatrogenic (Table 1). Primary spontaneous pneumothorax …

INTRODUCTION The discovery of malignant cells in pleural fluid and/or parietal pleura
signifies disseminated or advanced disease and a reduced life expectancy in patients with …

Patients with primary pneumothorax are best initially treated with aspiration and, if this is
successful, hospitalization is usually not necessary. Patients with secondary pneumothorax …

Malignant pleural effusions are a common clinical problem in patients with neoplastic
disease. In one post mortem series, malignant effusions were found in 15% of patients who …

Background Approximately half of all patients with metastatic cancer develop a malignant
pleural effusion which is likely to lead to a significant reduction in quality of life secondary to …

Background Many patients with lung cancer will develop symptoms related to their disease
process or the treatment they are receiving. These symptoms can be as debilitating as the …

Background Talc is the most effective chemical pleurodesis agent for patients with malignant
pleural effusion. However, concerns have arisen about the safety of intrapleural application …

Objectives: To review our experience with thoracoscopyand talc poudrage during the
previous 15 years with regards toefficacy, side effects, morbidity, and mortality. Methods: Six …

Spontaneous pneumothorax remains a significant health problem. However, with time, there
have been improvements in pathogenesis, diagnostic procedures and both medical and …